380 related articles for article (PubMed ID: 23966023)
1. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
de la Fuente-Sandoval C; León-Ortiz P; Azcárraga M; Stephano S; Favila R; Díaz-Galvis L; Alvarado-Alanis P; Ramírez-Bermúdez J; Graff-Guerrero A
JAMA Psychiatry; 2013 Oct; 70(10):1057-66. PubMed ID: 23966023
[TBL] [Abstract][Full Text] [Related]
2. Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Jung-Cook H; Solís-Vivanco R; Graff-Guerrero A; Shungu DC
Biol Psychiatry; 2018 Mar; 83(6):475-483. PubMed ID: 29132653
[TBL] [Abstract][Full Text] [Related]
3. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
4. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.
Bojesen KB; Ebdrup BH; Jessen K; Sigvard A; Tangmose K; Edden RAE; Larsson HBW; Rostrup E; Broberg BV; Glenthøj BY
Psychol Med; 2020 Oct; 50(13):2182-2193. PubMed ID: 31524118
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia.
Sarpal DK; Robinson DG; Lencz T; Argyelan M; Ikuta T; Karlsgodt K; Gallego JA; Kane JM; Szeszko PR; Malhotra AK
JAMA Psychiatry; 2015 Jan; 72(1):5-13. PubMed ID: 25372846
[TBL] [Abstract][Full Text] [Related]
6. Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients.
Reyes-Madrigal F; Guma E; León-Ortiz P; Gómez-Cruz G; Mora-Durán R; Graff-Guerrero A; Kegeles LS; Chakravarty MM; de la Fuente-Sandoval C
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110473. PubMed ID: 34748864
[TBL] [Abstract][Full Text] [Related]
7. Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.
de la Fuente-Sandoval C; León-Ortiz P; Favila R; Stephano S; Mamo D; Ramírez-Bermúdez J; Graff-Guerrero A
Neuropsychopharmacology; 2011 Aug; 36(9):1781-91. PubMed ID: 21508933
[TBL] [Abstract][Full Text] [Related]
8. Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients.
Sivaraman S; Kraguljac NV; White DM; Morgan CJ; Gonzales SS; Lahti AC
Psychiatry Res Neuroimaging; 2018 Nov; 281():101-106. PubMed ID: 30286325
[TBL] [Abstract][Full Text] [Related]
9. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
[TBL] [Abstract][Full Text] [Related]
10. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.
Goghari VM; Smith GN; Honer WG; Kopala LC; Thornton AE; Su W; Macewan GW; Lang DJ
Schizophr Res; 2013 Sep; 149(1-3):149-55. PubMed ID: 23830856
[TBL] [Abstract][Full Text] [Related]
11. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
12. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.
Jauhar S; McCutcheon R; Borgan F; Veronese M; Nour M; Pepper F; Rogdaki M; Stone J; Egerton A; Turkheimer F; McGuire P; Howes OD
Lancet Psychiatry; 2018 Oct; 5(10):816-823. PubMed ID: 30236864
[TBL] [Abstract][Full Text] [Related]
13. Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex.
Fan L; Liang L; Wang Y; Ma X; Yuan L; Ouyang L; He Y; Li Z; Li C; Chen X; Palaniyappan L
Neuropsychopharmacology; 2024 Apr; 49(5):845-853. PubMed ID: 37752221
[TBL] [Abstract][Full Text] [Related]
14. The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment.
Jauhar S; McCutcheon RA; Veronese M; Borgan F; Nour M; Rogdaki M; Pepper F; Stone JM; Egerton A; Vamvakas G; Turkheimer F; McGuire PK; Howes OD
Transl Psychiatry; 2023 May; 13(1):184. PubMed ID: 37253720
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammation and cortical neurochemistry in never-medicated first episode-psychosis individuals.
León-Ortiz P; Rivera-Chávez LF; Torres-Ruíz J; Reyes-Madrigal F; Carrillo-Vázquez D; Moncada-Habib T; Cassiano-Quezada F; Cadenhead KS; Gómez-Martín D; de la Fuente-Sandoval C
Brain Behav Immun; 2023 Jul; 111():270-276. PubMed ID: 37149107
[TBL] [Abstract][Full Text] [Related]
16. Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis.
Ikuta T; Robinson DG; Gallego JA; Peters BD; Gruner P; Kane J; John M; Sevy S; Malhotra AK; Szeszko PR
Psychiatry Res; 2014 Feb; 221(2):127-34. PubMed ID: 24120303
[TBL] [Abstract][Full Text] [Related]
17. Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate.
Dempster K; Jeon P; MacKinley M; Williamson P; Théberge J; Palaniyappan L
Mol Psychiatry; 2020 Aug; 25(8):1640-1650. PubMed ID: 32205866
[TBL] [Abstract][Full Text] [Related]
18. Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients.
Birur B; Kraguljac NV; VerHoef L; Morgan CJ; Jindal RD; Reid MA; Luker A; Lahti AC
Transl Psychiatry; 2020 Jan; 10(1):15. PubMed ID: 32066680
[TBL] [Abstract][Full Text] [Related]
19. Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study.
Girgis RR; Diwadkar VA; Nutche JJ; Sweeney JA; Keshavan MS; Hardan AY
Schizophr Res; 2006 Feb; 82(1):89-94. PubMed ID: 16413757
[TBL] [Abstract][Full Text] [Related]
20. Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration.
Egerton A; Griffiths K; Casetta C; Deakin B; Drake R; Howes OD; Kassoumeri L; Khan S; Lankshear S; Lees J; Lewis S; Mikulskaya E; Millgate E; Oloyede E; Pollard R; Rich N; Segev A; Sendt KV; MacCabe JH
Neuropsychopharmacology; 2023 Feb; 48(3):567-575. PubMed ID: 36456813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
